Navigation Links
Novation Releases its Drug Price Forecast for 2012-13
Date:3/26/2012

IRVING, Texas, March 26, 2012 /PRNewswire/ -- Novation, the leading health care supply contracting company, today announces the release of its Drug Price Forecast Summary Report, Winter 2012.  This summary report highlights key insights offered in Novation's full Drug Price Forecast, including projected drug price inflation summary projections and overviews of the top five therapeutic categories based on purchase volume.

Novation's semi-annual Drug Price Forecast is designed to offer information and support resources to aide in the development of annual drug budget projections. The full report, available exclusively to members of VHA, UHC and Provista, features additional information including:

  • detailed category overviews for the top twelve therapeutic categories based on purchase volume;
  • price inflation projections by product and therapeutic category; and
  • an interactive Drug Budget Worksheet enabling the addition of a facility's purchase history by generic product or therapeutic category to build a pharmaceutical budget for using Novation Drug Price Forecast projections.

Novation's Drug Price Forecast estimates the change in the cost of pharmaceuticals purchased from July 1, 2012, through June 30, 2013. The forecast is focused on pharmaceutical use in the acute care hospital setting and is based on purchase history and data associated with Novation Pharmacy Program participant health care organizations.

The summary report specifically reviews the therapeutic categories of antineoplastics, plasma critical care products, hematopoietic agents, disease-modifying anti-rheumatic drugs, and heparins.

"As hospitals are squeezed more and more tightly by today's financial pressures, the projections in our report can be very helpful for making budget projections," said David Jameson, vice president, pharmacy, Novation.  "Many factors affect the financial predictions in this report.  For example, the number of competitors in the market and the approval and adoption of new drugs are both factors that can have a significant impact on pharmaceutical pricing."

"Ultimately, we want to provide as much information as possible to the members we serve to help them manage their supply costs and understand the emerging pharmaceutical trends," said Jameson.

To view the summary report, please visit https://www.novationco.com/pressroom/industry_info.  VHA, UHC and Provista members may access the full Drug Price Forecast report at Marketplace|Procure.

About Novation, Winner of the Ethics Inside® Certification
Founded in 1998, Novation is the leading health care supply contracting company for the more than 65,000 members of VHA Inc. and UHC, two national health care alliances, and Provista, LLC. Novation provides alliance members sourcing services, as well as information and data services. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 600 suppliers. VHA, UHC and Provista members used Novation contracts to purchase more than $40 billion in 2011. Novation recently earned the coveted Ethics Inside® Certification from the Ethisphere Institute, a leading international think tank dedicated to the research and promotion of best practices in corporate ethics and compliance, and is the only health care GPO to earn this distinction.


'/>"/>
SOURCE Novation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Novation Releases Its Latest Transcatheter Cardiovascular Therapeutics Report to Help Members Understand and Prepare for New Technologies
2. Linet Awarded New Technology Agreement from Novation, the Nations Largest Healthcare Purchasing Organization
3. Clinical Innovation Outsourcing Awards Deadline Extension: Friday 2nd March
4. Lilly Introduces Global Innovation Starts Here Initiative to Foster Innovation and Quality Science
5. Frost & Sullivan New Product Innovation Award Presented to Brainsway for Its Deep Transcranial Magnetic Stimulation (dTMS) Device
6. Novation Applauds New FDA Guidance Documents on Biosimilars
7. Young Innovations, Inc. Announces Record EPS for the Quarter and Record Sales and EPS for the Year
8. Innovation Day 2012: a Time To Inform and Inspire
9. BioParadox Announces Partnership with Fogarty Institute for Innovation
10. Celebrity Chef Danny Boome Announces Launch of Arthriving.com, A New Online Resource Featuring Smart Solutions And Product Innovations For People With Arthritis
11. DLP® LightCrafter™ From Texas Instruments: Enabling Big Innovations In Light Steering From A Compact, Ready-To-Use Module
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2017)... Australien, 24. Februar 2017 ITL Limited, ... des Gesundheitsbereiches, ist erfreut, für das zum 31. ... entsprechenden Vorjahreszeitraum exzellente Ergebnisse vorlegen zu können. Eine ... zum Wachstum" finden Sie hier . ... nach Steuern 2,12 Millionen USD (Dez. 2015: 1,04 Millionen USD; +104 %) ...
(Date:2/24/2017)... -- This report analyzes the worldwide markets for Chiral Technology ... Products: Intermediates, Analytical, and Others. The End Use markets ... The report provides separate comprehensive analytics for the US, ... , and Rest of World. Annual estimates and forecasts ... a six-year historic analysis is provided for these markets. ...
(Date:2/24/2017)... Feb 24, 2017 Medivir AB ... for a new Board of Directors that will be ... Nomination Committee comprises representatives of the company,s three largest ... 2016 who have accepted a seat on the Nomination ... of the 2016-2017 Nomination Committee was as follows:  ...
Breaking Medicine Technology:
(Date:2/26/2017)... ... , ... IndustryArchive.Org . is announcing a new way for B2B Sellers ... only pay for B.A.N.T. quality sales leads based on the Sellers decision to purchase ... reality that B2B buyers are controlling the sales process via the Internet and that ...
(Date:2/26/2017)... ... , ... ODH, Inc.™ announced today it will exhibit and speak at ... Hotel in Arlington, VA. ODH’s director of medical strategy, Candace Saldarini, M.D., will present ... population health management. , ODH will also have an exhibit booth where attendees may ...
(Date:2/26/2017)... ... February 26, 2017 , ... Occupational pesticide exposure ... a specific LRRK2 mutation, according to a study released today at the 1st ... of a link between pesticides and incidence of sporadic PD through occupational exposure. ...
(Date:2/24/2017)... (PRWEB) , ... February 24, 2017 , ... ... its newly designed TaskMate Go. Core benefits and advantages built into the home ... a stylish, functional look and feel. Ability to gain the benefits embedded in ...
(Date:2/24/2017)... ... February 24, 2017 , ... Only two months after the ... Market (ILTM) show in Cannes (France), XO Private has initiated a second print-run of ... book measures almost a metre across when open, weighs in at more than six ...
Breaking Medicine News(10 mins):